Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693

Neuropathology of Cognitively Normal Elderly

Knopman, D. S., Parisi, J. E., Salviati, A., Floriach-Robert, M., Boeve, B. F., Ivnik, R. J., Smith, G. E., Dickson, D. W., Johnson, K. A., Petersen, L. E., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.11.1087 · Cited by 674

Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study

Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662

Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium

Alafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467

Two Types of Sporadic Cerebral Amyloid Angiopathy

Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446

The neuropathological diagnosis of Alzheimer's disease

DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894

Pathology of Neurodegenerative Diseases

Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665

The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease

Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540

Aging-related tau astrogliopathy (ARTAG): Harmonized evaluation strategy

Kovacs, G. G., Ferrer, I., Grinberg, L. T., Alafuzoff, I., Attems, J., Budka, H., Cairns, N. J., Crary, J. F., Duyckaerts, C., Ghetti, B., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1509-x · Cited by 532

Vascular pathology in the aged human brain

Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

Murray, M. E., Lowe, V. J., Graff-Radford, N. R., Liesinger, A. M., Cannon, A., Przybelski, S. A., Rawal, B., Parisi, J. E., Petersen, R. C., Kantarci, K., et al. (2015) · Brain · doi:10.1093/brain/awv050 · Cited by 324

ApoE attenuates unresolvable inflammation by complex formation with activated C1q

Yin, C., Ackermann, S., Ma, Z., Mohanta, S. K., Zhang, C., Li, Y., Nietzsche, S., Westermann, M., Peng, L., Hu, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0336-8 · Cited by 305

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

Schoonenboom, N. S. M., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A. L., Blankenstein, M. A., Rozemuller, A. J., Scheltens, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31823ed0f0 · Cited by 302

Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies

Ihara, M., Polvikoski, T. M., Hall, R., Slade, J. Y., Perry, R. H., Oakley, A. E., Englund, E. M., O'Brien, J. T., Ince, P. G., & Kalaria, R. N. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0635-8 · Cited by 251

Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

Walker, L., McAleese, K. E., Thomas, A. J., Johnson, M. A., Martin-Ruiz, C. M., Parker, C., Colloby, S. J., Jellinger, K. A., & Attems, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1406-3 · Cited by 224

Altered Proteins in the Aging Brain

Elobeid, A., Libard, S., Leino, M., Popova, S. N., & Alafuzoff, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw002 · Cited by 202

Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts

Nelson, P. T., Brayne, C., Flanagan, M. E., Abner, E. L., Agrawal, S., Attems, J., Castellani, R. J., Corrada, M. M., Cykowski, M. D., Di, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02444-1 · Cited by 187

Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease

Dijkstra, A. A., Voorn, P., Berendse, H. W., Groenewegen, H. J., Bank, N. B., Rozemüller, A. J. M., & van de Berg, W. D. J. (2014) · Movement Disorders · doi:10.1002/mds.25952 · Cited by 193

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders

Mundiñano, I.-C., Caballero, M. C., Ordóñez, C., Hernández, M., DiCaudo, C., Marcilla, I., Erro, M. E., Tuñon, M.-T., & Luquín, M. R. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0830-2 · Cited by 174

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson’s Disease

Dijkstra, A. A., Ingrassia, A., de Menezes, R. X., van Kesteren, R. E., Rozemuller, A. J. M., Heutink, P., & van de Berg, W. D. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128651 · Cited by 167

Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels

Lattanzio, F., Abu‐Rumeileh, S., Franceschini, A., Kai, H., Amore, G., Poggiolini, I., Rossi, M., Baiardi, S., McGuire, L. I., Ladogana, A., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1683-0 · Cited by 168

[ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid‐β pathology

Thal, D. R., Beach, T. G., Zanette, M., Heurling, K., Chakrabarty, A., Ismail, A., Smith, A. P. L., & Buckley, C. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.018 · Cited by 159

Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation

Castillo, E., Leon, J., Mazzei, G., Abolhassani, N., Haruyama, N., Saito, T., Saido, T., Hokama, M., Iwaki, T., Ohara, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17999-3 · Cited by 158

Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies

Hepp, D. H., Vergoossen, D. L. E., Huisman, E., Lemstra, A. W., Bank, N. B., Berendse, H. W., Rozemüller, A. J. M., Foncke, E. M. J., & van de Berg, W. D. J. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw070 · Cited by 159

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease

Balasa, M., Gelpí, E., Antonell, A., Rey, M. J., Sánchez‐Valle, R., Molinuevo, J. L., & Lladó, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31821a44dd · Cited by 157

Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study

Šalković‐Petrišić, M., Barilar, J. O., Brückner, M. K., Hoyer, S., Arendt, T., & Riederer, P. F. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0651-4 · Cited by 136

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets

Li, T., Vandesquille, M., Koukouli, F., Dudeffant, C., Youssef, I., Lenormand, P., Ganneau, C., Maskos, U., Czech, C., Grueninger, F., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.019 · Cited by 143

Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesPreprint

Braak, H., & Tredici, K. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023630 · Cited by 132

Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study Experience

Wharton, S. B., Brayne, C., Savva, G. M., Matthews, F. E., Forster, G., Simpson, J. E., Lace, G., & Ince, P. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-091402 · Cited by 129

Alzheimer disease

Calderón‐Garcidueñas, A. L., & Duyckaerts, C. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00023-7 · Cited by 126

Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimerʼs Disease

Cooper, G. J. S. (2011) · Drugs · doi:10.2165/11591370-000000000-00000 · Cited by 115

Dura mater is a potential source of Aβ seeds

Kovács, G. G., Lutz, M. I., Ricken, G., Ströbel, T., Höftberger, R., Preusser, M., Regelsberger, G., Hönigschnabl, S., Reiner, A., Fischer, P. A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1565-x · Cited by 110

Post‐mortem findings in 10 patients with presumed normal‐pressure hydrocephalus and review of the literature

Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Sutela, A., Vanninen, R. L., Jääskeläinen, J. E., Soininen, H. S., & Alafuzoff, I. I. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01195.x · Cited by 101

Brain banking for neurological disorders

Samarasekera, N., Salman, R. A., Huitinga, I., Klioueva, N. M., McLean, C., Kretzschmar, H. A., Smith, C., & Ironside, J. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70202-3 · Cited by 96

Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology

Skogseth, R. E., Hortobágyi, T., Soennesyn, H., Chwiszczuk, L. J., Ffytche, D. H., Rongve, A., Ballard, C. G., & Aarsland, D. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170274 · Cited by 96

Copathology in Progressive Supranuclear Palsy: Does It Matter?

Ječmenica‐Lukić, M., Kurz, C., Respondek, G., Grau‐Rivera, O., Compta, Y., Gelpí, E., Troakes, C., Barcelona Brain Bank collaborative group, T. M. P. S. G., Swieten, J. C. V., Giese, A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28011 · Cited by 93

Tau, prions and Aβ: the triad of neurodegeneration

Reiniger, L., Lukić, A., Linehan, J. M., Rudge, P., Collinge, J., Mead, S., & Brandner, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0691-0 · Cited by 95

Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease

Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94

Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy

Manousopoulou, A., Gatherer, M., Smith, C., Nicoll, J. A. R., Woelk, C. H., Johnson, M., Kalaria, R. N., Attems, J., Garbis, S. D., & Carare, R. O. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12342 · Cited by 90

How golden is the gold standard of neuropathology in dementia?

Scheltens, P., & Rockwood, K. J. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.011 · Cited by 88

String Vessel Formation is Increased in the Brain of Parkinson Disease

Yang, P., Pavlovic, D., Waldvogel, H. J., Dragunow, M., Synek, B. J., Turner, C. P., Faull, R. L. M., & Guan, J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140454 · Cited by 77

Failure to detect an association between self‐reported traumatic brain injury and Alzheimer's disease neuropathology and dementia

Sugarman, M. A., McKee, A. C., Stein, T. D., Tripodis, Y., Besser, L. M., Martin, B. M., Palmisano, J. N., Steinberg, E. G., O’Connor, M. K., Au, R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.015 · Cited by 77

Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy

Richard, E., Carrano, A., Hoozemans, J. J., van Horssen, J., van Haastert, E. S., Eurelings, L. S., de Vries, H. E., Thal, D. R., Eikelenboom, P., van Gool, W. A., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fab558 · Cited by 71

Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease

Ryan, N. S., Biessels, G. J., Kim, L. G., Nicholas, J. M., Barber, P. A., Walsh, P., Gami‐Patel, P., Morris, H. R., de Bastos-Leite, A. J., Schott, J. M., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.026 · Cited by 72

Sleep disorders in neurodegenerative diseases

Raggi, A., & Ferri, R. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03034.x · Cited by 68

Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus–pericoerulear complex by three-dimensional imaging

Gilvesy, A., Husén, E., Maglóczky, Z., Mihály, O. S., Hortobágyi, T., Kanatani, S., Heinsen, H., Renier, N., Hökfelt, T. G. M., Mulder, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02477-6 · Cited by 77

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia

Fujishiro, H., Iseki, E., Higashi, S., Kasanuki, K., Murayama, N., Togo, T., Katsuse, O., Uchikado, H., Aoki, N., Kosaka, K., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.036 · Cited by 70

The need to unify neuropathological assessments of vascular alterations in the ageing brain

Alafuzoff, I., Gelpi, E., Al-Sarraj, S., Arzberger, T., Attems, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Englund, E., et al. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.06.001 · Cited by 65

To stage, or not to stage

Tredici, K. D., & Braak, H. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.008 · Cited by 68

The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study

Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Maurage, C., & Pasquier, F. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03329.x · Cited by 64

Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort

Selvackadunco, S., Langford, K., Shah, Z., Hurley, S. M., Bódi, I., King, A., Aarsland, D., Troakes, C., & Al‐Sarraj, S. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-018-01967-w · Cited by 63

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future

Shakir, M., & Dugger, B. N. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab122 · Cited by 58

Prenatal high‐fat diet alters the cerebrovasculature and clearance of β‐amyloid in adult offspring

Hawkes, C. A., Gentleman, S., Nicoll, J. A. R., & Carare, R. O. (2014) · The Journal of Pathology · doi:10.1002/path.4468 · Cited by 56

Correlations Between Mini-Mental State Examination Score, Cerebrospinal Fluid Biomarkers, and Pathology Observed in Brain Biopsies of Patients With Normal-Pressure Hydrocephalus

El‐Obeid, A., Laurell, K., Cesarini, K. G., & Alafuzoff, I. I. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000191 · Cited by 56

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Thal, D. R., Beach, T. G., Zanette, M., Lilja, J., Heurling, K., Chakrabarty, A., Ismail, A., Farrar, G., Buckley, C. J., & Smith, A. P. L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1897-9 · Cited by 58

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)

Kovács, G. G., Xie, S. X., Lee, E. B., Robinson, J. L., Caswell, C., Irwin, D. J., Toledo, J. B., Johnson, V. E., Smith, D. H., Alafuzoff, I. I., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx041 · Cited by 54

Antemortem CSF A β 42/A β 40 ratio predicts Alzheimer's disease pathology better than A β 42 in rapidly progressive dementias

Baiardi, S., Abu‐Rumeileh, S., Rossi, M., Zenesini, C., Bartoletti‐Stella, A., Polischi, B., Capellari, S., & Parchi, P. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.697 · Cited by 53

Novel Diagnostic Tools for Identifying Cognitive Impairment in Dogs: Behavior, Biomarkers, and Pathology

Vikartovská, Z., Farbáková, J., Smolek, T., Hanes, J., Žilka, N., Horňáková, Ľ., Humeník, F., Maloveská, M., Hudáková, N., & Cizkova, D. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.551895 · Cited by 52

Comparison of Semi-Quantitative Scoring and Artificial Intelligence Aided Digital Image Analysis of Chromogenic Immunohistochemistry

Bencze, J., Szarka, M., Kóti, B., Seo, W., Hortobágyi, T. G., Bencs, V., Módis, L., & Hortobágyi, T. (2021) · Biomolecules · doi:10.3390/biom12010019 · Cited by 50

Characteristics of the tissue section that influence the staining outcome in immunohistochemistry

Libard, S., Cerjan, D., & Alafuzoff, I. I. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1742-1 · Cited by 52

Associations Between Plasma Biomarkers and Cognition in Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study

Tsai, C., Liang, C., Lee, J., Su, M., Lin, C., Chu, H., Tsai, C., Lin, G., Lin, Y., & Yang, F. (2019) · Journal of Clinical Medicine · doi:10.2139/ssrn.3464407 · Cited by 48

Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls

Jonkman, L. E., Graaf, Y. G.-D., Bulk, M., Kaai, E., Pouwels, P. J. W., Barkhof, F., Rozemüller, A. J. M., van der Weerd, L., Geurts, J. J. G., & van de Berg, W. D. J. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101698 · Cited by 44

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

Thal, D. R., Ronisz, A., Tousseyn, T., Upadhaya, A. R., Balakrishnan, K., Vandenberghe, R. R., Vandenbulcke, M., Arnim, C. A. F. V., Otto, M., Beach, T. G., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0837-9 · Cited by 44

Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies

Frigerio, I., Bouwman, M. M. A., Noordermeer, R. T. G. M. M., Podobnik, E., Popovic, M. M., Timmermans, E., Rozemüller, A. J. M., van de Berg, W. D. J., & Jonkman, L. E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01711-w · Cited by 43

Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study

Vromen, E. M., de Boer, S. C. M., Teunissen, C. E., Rozemüller, A. J. M., Sieben, A., Bjerke, M., Initiative, A. D. N., Visser, P. J., Bouwman, F. H., Engelborghs, S., et al. (2022) · Brain · doi:10.1093/brain/awac158 · Cited by 45

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease

Frigerio, I., Boon, B. D. C., Lin, C., Graaf, Y. G.-D., Bol, J. G. J. M., Preziosa, P., Twisk, J. W. R., Barkhof, F., Hoozemans, J. J. M., Bouwman, F. H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab281 · Cited by 38

Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles

Navarro, P. P., Genoud, C., Castaño‐Díez, D., Graff-Meyer, A., Lewis, A. J., de Gier, Y., Lauer, M. E., Britschgi, M., Bohrmann, B., Frank, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36223-4 · Cited by 40

Thinking Outside the Box: Alzheimer-Type Neuropathology That Does Not Map Directly Onto Current Consensus Recommendations

Nelson, P. T., Kukull, W. A., & Frosch, M. P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d8db07 · Cited by 37

Making the Diagnosis of Frontotemporal Lobar Degeneration

Bigio, E. H. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0075-ra · Cited by 38

Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys

Mundiñano, I.-C., Hernández, M., DiCaudo, C., Ordóñez, C., Marcilla, I., Tuñón, M. J., & Luquín, M. R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1144-3 · Cited by 37

A History of Senile Plaques: From Alzheimer to Amyloid Imaging

Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 37

Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis

Abu‐Rumeileh, S., Capellari, S., & Parchi, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171181 · Cited by 35

Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

Frigerio, I., Laansma, M. A., Lin, C., Hermans, E. J. M., Bouwman, M. M. A., Bol, J. G. J. M., Graaf, Y. G.-D., Hepp, D. H., Rozemüller, A. J. M., Barkhof, F., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-022-00328-8 · Cited by 35

Regional differences in gene expression and promoter usage in aged human brains

Pardo, L. M., Rizzu, P., Francescatto, M., Vitezic, M., Leday, G. G. R., Sanchez, J. S., Khamis, A. M., Takahashi, H., van de Berg, W. D. J., Medvedeva, Y. A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.005 · Cited by 36

Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium

Alafuzoff, I. I., Pikkarainen, M., Neumann, M., Arzberger, T., Al‐Sarraj, S., Bódi, I., Bogdanović, N., Bugiani, O., Ferrer, I., Gelpí, E., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1304-1 · Cited by 33

Long‐Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings

Ječmenica‐Lukić, M., Respondek, G., Kurz, C., Compta, Y., Gelpí, E., Ferguson, L. W., Rajput, A. H., Troakes, C., the MDS‐endorsed PSP study group, Swieten, J. C. V., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26455 · Cited by 32

A comparison of Aβ amyloid pathology staging systems and correlation with clinical diagnosis

Boluda, S., Toledo, J. B., Irwin, D. J., Raible, K. M., Byrne, M., Lee, E. B., Lee, V. M. ‐., & Trojanowski, J. Q. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1308-9 · Cited by 31

Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease

Libard, S., & Alafuzoff, I. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0748-9 · Cited by 29

Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation

Martikainen, P., Pikkarainen, M., Pöntynen, K., Hiltunen, M. O., Lehtovirta, M., Tuisku, S., Soininen, H. S., & Alafuzoff, I. I. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01046.x · Cited by 28

Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches

on behalf of the Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Wang, D. Y. Q., Parikh, C. R., Matthews, F. E., Brayne, C., & Ince, P. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0858-4 · Cited by 32

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases

de Ruyter, F. J. H., Evers, M. J. A. P., Morrema, T. H. J., Dijkstra, A. A., den Haan, J., Twisk, J. W. R., de Boer, J. F., Scheltens, P., Bouwman, F. H., Verbraak, F. D., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02769-z · Cited by 27

TAR-DNA binding protein-43 and alterations in the hippocampus

Rauramaa, T. H., Pikkarainen, M., Englund, E. M., Ince, P. G., Jellinger, K. A., Paetau, A. E., & Alafuzoff, I. I. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0574-5 · Cited by 27

β‐amyloid and tau pathology in the aging feline brain

Fiock, K. L., Smith, J. D., Crary, J. F., & Hefti, M. M. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24741 · Cited by 31

Novel Antibody Capture Assay for Paraffin‐Embedded Tissue Detects Wide‐Ranging Amyloid Beta and Paired Helical Filament–Tau Accumulation in Cognitively Normal Older Adults

Postupna, N. O., Rose, S. E., Bird, T. D., Gonzalez‐Cuyar, L. F., Sonnen, J. A., Larson, E. B., Keene, C. D., & Montine, T. J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00542.x · Cited by 26

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies

Chatterjee, M., van Steenoven, I., Huisman, E., Oosterveld, L. P., Berendse, H. W., van der Flier, W. M., del Campo, M., Lemstra, A. W., van de Berg, W. D. J., & Teunissen, C. E. (2020) · Biomolecules · doi:10.3390/biom10081177 · Cited by 26

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

Thal, D. R., Ronisz, A., Tousseyn, T., Upadhaya, A. R., Balakrishnan, K., Vandenberghe, R. R., Vandenbulcke, M., Arnim, C. A. F. V., Otto, M., Beach, T. G., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01005-5 · Cited by 25

Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer’s-like mouse models

Kumar, S., Lemere, C. A., & Walter, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00959-w · Cited by 24

Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk

Chew, E. G. Y., Liu, Z., Li, Z., Chung, S. J., Lian, M. M., Tandiono, M., Heng, Y. J., Ng, E., Tan, L. C. S., Chng, W. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00760-7 · Cited by 23

Amyloid-Beta Pathology and Cognitive Performance in Centenarians

Rohde, S. K., Luimes, M. C., Lorenz, L. M. C., Fierro‐Hernández, P., Rozemüller, A. J. M., Hulsman, M., Zhang, M., Graat, M., van der Hoorn, M. E., Daatselaar, D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1734 · Cited by 26

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins

Rossi, M., Kai, H., Baiardi, S., Bartoletti‐Stella, A., Carlà, B., Zenesini, C., Capellari, S., Kitamoto, T., & Parchi, P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0706-6 · Cited by 24

Alzheimer’s Amyloid β Peptide Induces Angiogenesis in an Alzheimer’s Disease Model Mouse through Placental Growth Factor and Angiopoietin 2 Expressions

Sheikh, A. M., Yano, S., Tabassum, S., Mitaki, S., Michikawa, M., & Nagai, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054510 · Cited by 23

Ageing-Related Neurodegeneration and Cognitive Decline

Alafuzoff, I. I., & Libard, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074065 · Cited by 27

Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide

Verwey, N. A., Hoozemans, J. J. M., Korth, C., van Royen, M. R., Prikulis, I., Wouters, D., Twaalfhoven, H. A. M., van Haastert, E. S., Schenk, D., Scheltens, P., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.797389 · Cited by 21

Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly

Alafuzoff, I. I., & Libard, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200925 · Cited by 21

Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases

Jellinger, K. A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02345-9 · Cited by 21

Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection

Rajab, M. A., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., Wang, D. Y. Q., & on behalf of the Cognitive Function and Ageing Neuropathology Study Group (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01195-9 · Cited by 19

Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles

Vizcarra, J. C., Pearce, T. M., Dugger, B. N., Keiser, M. J., Gearing, M., Crary, J. F., Kiely, E. J., Morris, M., White, B., Glass, J. D., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01691-x · Cited by 19

Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration

Hortobágyi, T., & Cairns, N. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00026-2 · Cited by 19

Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition

Roy, M., Cardoso, C., Dorieux, O., Malgorn, C., Epelbaum, S., Petit, F., Kraska, A., Brouillet, E., Delatour, B., Perret, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.017 · Cited by 21

Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4

Gawor, K., Verrept, S., Arekatla, G., Wouters, D., Ronisz, A., Hecht, M., Laureyssen, C., Donck, H. V., Lahaije, B., Ospitalieri, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70483 · Cited by 18

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [18F]PI-2620

Willroider, M., Roeber, S., Horn, A. K. E., Arzberger, T., Scheifele, M., Respondek, G., Sabri, O., Barthel, H., Patt, M., Mishchenko, O., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.684523 · Cited by 17

Dependency criterion based brain pathological age estimation of Alzheimer’s disease patients with MR scans

Initiative, A. D. N., Li, Y., Liu, Y., Wang, P., Wang, J., Xu, S., & Qiu, M. (2017) · BioMedical Engineering OnLine · doi:10.1186/s12938-017-0342-y · Cited by 16

Amyloid in skin and brain: What′s the link?

Schreml, S., Kaiser, E., Landthaler, M., Szeimies, R., & Babilas, P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01166.x · Cited by 16

Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium

Alafuzoff, I. I., Pikkarainen, M., Arzberger, T., Thal, D. R., Al‐Sarraj, S., Bell, J. E., Bódi, I., Budka, H., Capetillo‐Zarate, E., Ferrer, I., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0358-2 · Cited by 105

Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches

on behalf of the Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Wang, D. Y. Q., Parikh, C. R., Matthews, F. E., Brayne, C., & Ince, P. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0858-4 · Cited by 32

Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium

Alafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467

S1‐02‐05: Reproducibility in the assessment of Alzheimer's disease and Lewy body disease‐related pathologies: A study by Brain Net Europe

Alafuzoff, I. I. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.164

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490